Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.28 trillion and total revenue of $116.52 billion.
Market Cap
1.28T
Revenue
116.52B
Profits
-35.46B
PE Ratio
n/a
Profit Margin
-30.44%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 132.95B | 1.92% | 1,448,535 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 98.14B | 1.54% | 16,170,984 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 80.45B | -0.22% | 581,052 | 15.53B |
| 4 | ARGX | argenx SE | 55.20B | 2.34% | 656,637 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 43.94B | 0.51% | 571,814 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.64B | -1.15% | 1,876,708 | - |
| 7 | RPRX | Royalty Pharma plc | 35.74B | -0.16% | 2,741,940 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.12B | -2.43% | 1,177,498 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.58B | 5.38% | 16,840,406 | 7.53M |
| 10 | GMAB | Genmab A/S | 23.51B | 1.28% | 3,102,883 | 4.13B |
| 11 | INCY | Incyte Corporation | 22.99B | -2.73% | 1,403,311 | 5.82B |
| 12 | BNTX | BioNTech SE | 22.93B | 0.13% | 1,113,474 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.54B | -1.70% | 2,964,958 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 16.00B | 0.30% | 1,494,335 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 15.69B | 1.95% | 662,038 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.17B | 0.37% | 1,739,777 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.76B | -0.84% | 695,499 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.24B | 0.28% | 3,035,888 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.66B | -1.62% | 5,366,158 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.57B | -0.15% | 516,758 | 830.81M |
| 21 | TECH | Bio-Techne Corporation | 11.39B | 0.08% | 3,497,679 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.69B | -2.18% | 2,506,309 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.58B | -2.05% | 338,288 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 9.95B | -4.53% | 3,272,135 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.54B | -1.00% | 468,235 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.37B | -0.73% | 1,056,192 | 105.00M |
| 27 | TWST | Twist Bioscience Corporation | 9.35B | 4.51% | 2,636,389 | 431.80M |
| 28 | IBRX | ImmunityBio, Inc. | 9.16B | -1.48% | 11,454,630 | 165.79M |
| 29 | CAI | Caris Life Sciences, Inc. | 9.14B | 3.99% | 2,233,713 | 989.61M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.93B | 0.07% | 990,174 | 281.99M |
| 31 | CYTK | Cytokinetics, Incorporated | 8.74B | -1.70% | 1,080,526 | 67.67M |
| 32 | SYRE | Spyre Therapeutics, Inc. | 8.69B | 1.70% | 1,153,098 | - |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.31B | -0.14% | 1,371,520 | 669.50M |
| 34 | ABVX | ABIVAX Société Anonyme | 8.25B | 0.97% | 947,972 | 5.33M |
| 35 | AXSM | Axsome Therapeutics, Inc. | 8.19B | -2.05% | 524,755 | 776.57M |
| 36 | TGTX | TG Therapeutics, Inc. | 7.55B | -2.44% | 1,178,007 | 799.54M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.36B | -2.49% | 2,268,541 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 7.16B | -3.03% | 496,951 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.62B | -1.62% | 10,994,972 | 324.97M |
| 40 | LGND | Ligand Pharmaceuticals Incorporated | 6.28B | 2.73% | 222,540 | 290.54M |
| 41 | BLTE | Belite Bio, Inc | 6.17B | -0.51% | 113,766 | - |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.10B | -1.75% | 511,343 | 239.92M |
| 43 | IMVT | Immunovant, Inc. | 5.86B | -0.73% | 1,494,627 | - |
| 44 | MANE | Veradermics, Incorporated | 5.71B | 7.51% | 708,125 | - |
| 45 | CGON | CG Oncology, Inc. | 5.52B | 0.50% | 530,135 | 6.23M |
| 46 | KOD | Kodiak Sciences Inc. | 5.50B | -5.65% | 940,924 | - |
| 47 | COGT | Cogent Biosciences, Inc. | 5.46B | 0.61% | 2,216,579 | - |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.42B | -1.92% | 646,889 | 618.07M |
| 49 | ORKA | Oruka Therapeutics, Inc. | 5.29B | 1.05% | 953,372 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.24B | 3.97% | 4,600,583 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.23B | -0.48% | 944,163 | 1.01B |
| 52 | ERAS | Erasca, Inc. | 5.07B | -0.89% | 3,845,038 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.96B | 0.54% | 2,164,172 | 591.33M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.88B | 1.24% | 1,170,560 | 13.39M |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.77B | 1.14% | 2,906,445 | - |
| 56 | TNGX | Tango Therapeutics, Inc. | 4.55B | 6.85% | 5,558,376 | 53.81M |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 4.37B | -0.83% | 1,194,113 | 1.90M |
| 58 | EWTX | Edgewise Therapeutics, Inc. | 4.31B | -0.25% | 1,828,337 | - |
| 59 | RLAY | Relay Therapeutics, Inc. | 4.03B | -0.22% | 1,598,187 | 10.35M |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 4.01B | -2.89% | 1,688,742 | 463.98M |
| 61 | ABCL | AbCellera Biologics Inc. | 3.97B | 4.53% | 3,216,083 | 66.17M |
| 62 | LEGN | Legend Biotech Corporation | 3.61B | -2.00% | 1,559,722 | 1.27B |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.48B | -0.88% | 1,081,001 | 7.50M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | -1.22% | 1,409,867 | 1.14B |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.47B | -10.13% | 879,075 | 890.79M |
| 66 | PBLS | Parabilis Medicines, Inc. | 3.44B | 2.84% | 1,391,966 | 148.00K |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 0.31% | 648,772 | 234.13M |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | -0.75% | 945,908 | 606.33M |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.08B | -1.24% | 3,295,042 | - |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.06B | 1.38% | 2,052,398 | - |
| 71 | CELC | Celcuity Inc. | 3.01B | 2.60% | 1,590,616 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.00B | -1.23% | 1,789,806 | - |
| 73 | DNLI | Denali Therapeutics Inc. | 2.99B | -1.32% | 1,429,201 | 3.60M |
| 74 | IRON | Disc Medicine, Inc. | 2.92B | -4.38% | 4,600,974 | - |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.84B | -0.31% | 2,928,495 | 701.94M |
| 76 | ZLAB | Zai Lab Limited | 2.72B | -3.51% | 1,197,863 | 449.61M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.61B | 2.59% | 1,920,985 | 71.13M |
| 78 | MBX | MBX Biosciences, Inc. | 2.60B | 0.80% | 400,363 | - |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.57B | -0.05% | 1,252,726 | 7.12M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.48B | -0.36% | 1,168,187 | 156.04M |
| 81 | ADMA | ADMA Biologics, Inc. | 2.47B | -1.96% | 2,006,443 | 512.28M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 2.45B | 1.34% | 5,656,439 | - |
| 83 | RCUS | Arcus Biosciences, Inc. | 2.43B | -19.58% | 4,654,346 | 117.00M |
| 84 | PGEN | Precigen, Inc. | 2.36B | -3.37% | 5,969,733 | 85.72M |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.31B | -3.04% | 1,117,511 | 158.00K |
| 86 | FTRE | Fortrea Holdings Inc. | 2.29B | 5.62% | 2,473,417 | 2.68B |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | 0.96% | 783,233 | 311.51M |
| 88 | VERA | Vera Therapeutics, Inc. | 2.25B | 3.79% | 2,083,558 | - |
| 89 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | -1.01% | 1,062,423 | 959.90M |
| 90 | AGIO | Agios Pharmaceuticals, Inc. | 2.22B | 1.47% | 849,792 | 98.34M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -0.55% | 19,356,539 | 54.86M |
| 92 | PHVS | Pharvaris N.V. | 2.15B | -0.78% | 393,547 | - |
| 93 | VCEL | Vericel Corporation | 2.10B | 0.89% | 431,996 | 306.30M |
| 94 | IMNM | Immunome, Inc. | 2.04B | 0.45% | 1,543,903 | 4.02M |
| 95 | ZYME | Zymeworks Inc. | 2.00B | 4.48% | 1,318,869 | 37.13M |
| 96 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | 5.14% | 1,699,963 | 208.78M |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | -3.18% | 2,034,140 | 1.97B |
| 98 | LKFT | Lakefront Biotherapeutics NV | 1.95B | -0.55% | 133,987 | 1.13B |
| 99 | ADRX | ADARx Pharmaceuticals, Inc. | 1.92B | -3.11% | 441,510 | 6.13M |
| 100 | SEPN | Septerna, Inc. | 1.90B | 3.58% | 286,393 | 98.88M |
| 101 | XNCR | Xencor, Inc. | 1.87B | 0.88% | 1,479,576 | 104.97M |
| 102 | MLYS | Mineralys Therapeutics, Inc. | 1.87B | -2.22% | 808,546 | - |
| 103 | ZBIO | Zenas BioPharma, Inc. | 1.83B | -0.35% | 483,888 | 1.00M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 2.15% | 255,792 | - |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.82B | -0.47% | 2,650,540 | - |
| 106 | NVAX | Novavax, Inc. | 1.82B | -3.67% | 5,440,640 | 413.80M |
| 107 | MAZE | Maze Therapeutics, Inc. | 1.81B | 0.40% | 1,068,269 | 20.00M |
| 108 | VIR | Vir Biotechnology, Inc. | 1.79B | -1.58% | 1,136,654 | 303.23M |
| 109 | BHVN | Biohaven Ltd. | 1.77B | -0.51% | 1,443,717 | - |
| 110 | URGN | UroGen Pharma Ltd. | 1.73B | 1.34% | 776,971 | 188.73M |
| 111 | ABSI | Absci Corporation | 1.72B | 10.69% | 5,354,720 | 1.56M |
| 112 | BRVE | Braveheart Bio, Inc. | 1.72B | 3.80% | 224,144 | - |
| 113 | NUVB | Nuvation Bio Inc. | 1.70B | 1.68% | 4,503,405 | 169.90M |
| 114 | MESO | Mesoblast Limited | 1.70B | 3.38% | 555,437 | 120.25M |
| 115 | GENB | Generate Biomedicines, Inc. | 1.68B | 1.63% | 421,188 | 26.48M |
| 116 | KLRA | Kailera Therapeutics, Inc. | 1.67B | 0.23% | 1,282,098 | - |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.66B | -3.49% | 2,257,813 | 27.59M |
| 118 | IMCR | Immunocore Holdings plc | 1.65B | -1.56% | 1,159,320 | 430.78M |
| 119 | COAG | Hemab Therapeutics Holdings, Inc. | 1.65B | 3.42% | 388,257 | - |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.63B | -1.60% | 2,828,931 | 59.51M |
| 121 | QURE | uniQure N.V. | 1.57B | -0.13% | 1,115,535 | 18.67M |
| 122 | GPCR | Structure Therapeutics Inc. | 1.57B | -3.80% | 804,269 | - |
| 123 | RARE | Ultragenyx Pharmaceutical Inc. | 1.56B | -0.62% | 2,825,491 | 717.00M |
| 124 | TRAX | First Tracks Biotherapeutics, Inc. | 1.53B | 3.68% | 711,797 | - |
| 125 | INVA | Innoviva, Inc. | 1.51B | -1.74% | 441,647 | 440.00M |
| 126 | KRSA | Korsana Biosciences, Inc. | 1.48B | 4.87% | 129,773 | - |
| 127 | AAPG | Ascentage Pharma Group International | 1.46B | 2.64% | 1,485 | 94.61M |
| 128 | INBX | Inhibrx Biosciences, Inc. | 1.45B | 3.03% | 239,028 | 1.30M |
| 129 | ORIC | ORIC Pharmaceuticals, Inc. | 1.44B | 0.51% | 1,568,836 | - |
| 130 | ANAB | AnaptysBio, Inc. | 1.43B | 5.52% | 664,422 | 106.09M |
| 131 | OCUL | Ocular Therapeutix, Inc. | 1.42B | -2.56% | 2,491,817 | 52.06M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.42B | 0.64% | 724,289 | - |
| 133 | NBTX | Nanobiotix S.A. | 1.37B | 7.00% | 165,343 | 13.15M |
| 134 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | 0.24% | 3,511,182 | 5.49M |
| 135 | DMRA | Damora Therapeutics, Inc. | 1.33B | 4.16% | 682,732 | - |
| 136 | NKTR | Nektar Therapeutics | 1.31B | -2.42% | 619,302 | 54.59M |
| 137 | GHRS | GH Research PLC | 1.30B | -1.36% | 393,649 | - |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.27B | -4.32% | 246,884 | - |
| 139 | DRTS | Alpha Tau Medical Ltd. | 1.24B | 2.98% | 500,315 | - |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.20B | -14.67% | 2,161,677 | 20.00M |
| 141 | KARD | Kardigan, Inc. | 1.20B | -4.89% | 480,445 | - |
| 142 | SVRA | Savara Inc. | 1.19B | -1.89% | 2,086,762 | - |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.19B | -2.40% | 656,718 | - |
| 144 | SLN | Silence Therapeutics plc | 1.18B | 0.31% | 2,801,618 | 615.00K |
| 145 | OMER | Omeros Corporation | 1.18B | -1.75% | 698,094 | 38.42M |
| 146 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | -0.75% | 2,587,701 | 252.25M |
| 147 | VOR | Vor Biopharma Inc. | 1.12B | -0.47% | 817,609 | - |
| 148 | VSTM | Verastem, Inc. | 1.12B | -1.39% | 3,062,164 | 87.53M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.11B | 1.95% | 209,633 | - |
| 150 | REPL | Replimune Group, Inc. | 1.10B | 2.63% | 2,202,144 | - |
| 151 | LTGO | Latigo Biotherapeutics, Inc. | 1.08B | 7.15% | 173,758 | - |
| 152 | SPTX | Seaport Therapeutics, Inc. | 1.06B | 2.33% | 134,581 | - |
| 153 | IMTX | Immatics N.V. | 1.05B | 2.40% | 1,978,688 | 47.65M |
| 154 | JANX | Janux Therapeutics, Inc. | 1.04B | -1.57% | 587,297 | 24.00M |
| 155 | CTY | City Therapeutics, Inc. | 1.02B | -1.92% | 283,087 | 14.34M |
| 156 | MNKD | MannKind Corporation | 980.70M | -1.61% | 2,798,921 | 393.63M |
| 157 | JBIO | Jade Biosciences, Inc. | 962.23M | 1.82% | 931,928 | - |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 958.24M | 0.40% | 690,975 | - |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 957.22M | -1.23% | 1,078,210 | 28.73M |
| 160 | MGTX | MeiraGTx Holdings plc | 946.98M | -1.30% | 635,553 | 397.50M |
| 161 | AVBP | ArriVent BioPharma, Inc. | 942.76M | 1.43% | 1,489,214 | - |
| 162 | SGP | SpyGlass Pharma, Inc. | 926.84M | 5.93% | 86,088 | - |
| 163 | ANRO | Alto Neuroscience, Inc. | 915.13M | -4.47% | 663,459 | - |
| 164 | RIGL | Rigel Pharmaceuticals, Inc. | 913.07M | 1.60% | 195,890 | 276.79M |
| 165 | AKTS | Aktis Oncology, Inc. | 912.16M | 1.99% | 390,679 | 10.06M |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 910.45M | 0.05% | 255,338 | 99.00K |
| 167 | MLTX | MoonLake Immunotherapeutics | 906.39M | 3.20% | 1,163,559 | - |
| 168 | ALMS | Alumis Inc. | 881.45M | 1.64% | 1,230,135 | 7.40M |
| 169 | KURA | Kura Oncology, Inc. | 878.93M | -1.00% | 1,151,002 | 77.23M |
| 170 | OBX | Obsidian Therapeutics, Inc. | 860.50M | 5.13% | 332,844 | - |
| 171 | CRVS | Corvus Pharmaceuticals, Inc. | 845.42M | -1.76% | 868,812 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 827.00M | -3.46% | 3,026,405 | 181.72M |
| 173 | SLBT | SL Science Holding Limited | 826.89M | -3.33% | 107,387 | 3.27M |
| 174 | IVA | Inventiva S.A. | 825.96M | 8.90% | 5,244,124 | 2.81M |
| 175 | HELP | Helus Pharma Inc. | 787.59M | -1.46% | 935,761 | - |
| 176 | APMD | Apnimed, Inc. | 786.82M | 2.11% | 295,399 | 115.12M |
| 177 | ARDX | Ardelyx, Inc. | 779.96M | -2.49% | 3,017,433 | 450.89M |
| 178 | IAM | Iambic Therapeutics, Inc. | 748.93M | -1.31% | 473,808 | 18.25M |
| 179 | GERN | Geron Corporation | 745.27M | -6.45% | 8,702,041 | 204.56M |
| 180 | ANNX | Annexon, Inc. | 731.78M | 0.78% | 4,948,308 | - |
| 181 | ANL | Adlai Nortye Group Ltd. | 725.12M | 5.83% | 532,596 | 18.06M |
| 182 | OABI | OmniAb, Inc. | 714.59M | -0.91% | 3,176,453 | 38.46M |
| 183 | SGMT | Sagimet Biosciences Inc. | 708.38M | 2.57% | 1,578,098 | - |
| 184 | IMMX | Immix Biopharma, Inc. | 705.50M | -4.49% | 1,537,600 | - |
| 185 | SANA | Sana Biotechnology, Inc. | 703.50M | -0.42% | 2,401,695 | - |
| 186 | FDMT | 4D Molecular Therapeutics, Inc. | 697.18M | -3.66% | 2,019,204 | 92.01M |
| 187 | LXRX | Lexicon Pharmaceuticals, Inc. | 694.13M | -1.27% | 1,396,114 | 41.47M |
| 188 | SLDB | Solid Biosciences Inc. | 687.31M | 0.16% | 1,147,634 | - |
| 189 | PRME | Prime Medicine, Inc. | 677.82M | -2.81% | 2,438,162 | 4.07M |
| 190 | PHAR | Pharming Group N.V. | 675.61M | -1.03% | 10,920 | 366.48M |
| 191 | NVCT | Nuvectis Pharma, Inc. | 674.44M | 0.68% | 203,570 | - |
| 192 | DNA | Ginkgo Bioworks Holdings, Inc. | 674.08M | 1.52% | 1,777,200 | 132.42M |
| 193 | DSGN | Design Therapeutics, Inc. | 671.50M | -3.33% | 328,963 | - |
| 194 | AURA | Aura Biosciences, Inc. | 669.93M | -1.52% | 933,552 | - |
| 195 | ACHV | Achieve Life Sciences, Inc. | 669.90M | - | 2,468,984 | - |
| 196 | WVE | Wave Life Sciences, Inc. | 664.05M | -1.46% | 2,172,953 | 65.37M |
| 197 | AVTX | Avalo Therapeutics, Inc. | 657.50M | -0.81% | 930,208 | 59.00K |
| 198 | ATTO | Attovia Therapeutics, Inc. | 647.33M | 1.00% | 279,887 | 1.80M |
| 199 | CADL | Candel Therapeutics, Inc. | 640.46M | -3.13% | 1,102,645 | - |
| 200 | GYRE | Gyre Therapeutics, Inc. | 625.60M | -4.38% | 131,239 | 109.82M |
| 201 | CLYM | Climb Bio, Inc. | 624.33M | 0.65% | 930,384 | - |
| 202 | OLMA | Olema Pharmaceuticals, Inc. | 616.86M | -2.76% | 1,236,202 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 615.22M | -1.05% | 500,580 | 136.07M |
| 204 | CRMD | CorMedix Inc. | 607.19M | 2.91% | 1,049,666 | 462.25M |
| 205 | DBVT | DBV Technologies S.A. | 579.14M | 1.48% | 1,409,967 | 5.04M |
| 206 | ETRA | Electra Therapeutics, Inc. | 568.04M | 2.72% | 126,063 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 563.69M | 0.77% | 250,361 | 11.88M |
| 208 | PBYI | Puma Biotechnology, Inc. | 562.66M | 1.30% | 306,256 | 231.24M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 560.83M | 1.06% | 2,662,726 | 8.22M |
| 210 | STTK | Shattuck Labs, Inc. | 560.03M | -4.45% | 1,197,998 | 1.00M |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 558.39M | -3.83% | 784,163 | 239.66M |
| 212 | MDXG | MiMedx Group, Inc. | 545.14M | -11.58% | 2,604,125 | 355.17M |
| 213 | DRUG | Bright Minds Biosciences Inc. | 543.82M | -8.62% | 156,349 | - |
| 214 | FTH | Faeth Therapeutics, Inc. | 531.54M | -1.06% | 182,411 | - |
| 215 | ENTX | Entera Bio Ltd. | 530.46M | 0.99% | 784,597 | 42.00K |
| 216 | VALN | Valneva SE | 526.10M | -2.28% | 7,259 | 163.30M |
| 217 | CTMX | CytomX Therapeutics, Inc. | 522.96M | -4.38% | 3,110,980 | 18.30M |
| 218 | NGNE | Neurogene Inc. | 521.90M | 2.68% | 588,807 | 925.00K |
| 219 | EPRX | Eupraxia Pharmaceuticals Inc. | 506.03M | 1.84% | 348,313 | - |
| 220 | BLSM | BlossomHill Therapeutics, Inc. | 495.84M | 8.33% | 76,269 | - |
| 221 | ARVN | Arvinas, Inc. | 493.99M | -1.37% | 653,594 | 316.70M |
| 222 | OCS | Oculis Holding AG | 485.83M | 5.47% | 324,100 | 1.45M |
| 223 | MNPR | Monopar Therapeutics Inc. | 485.63M | -2.53% | 87,274 | - |
| 224 | OVID | Ovid Therapeutics Inc. | 482.39M | 4.66% | 5,005,039 | 1.58M |
| 225 | RGNX | REGENXBIO Inc. | 473.31M | -3.11% | 945,329 | 174.48M |
| 226 | DMAC | DiaMedica Therapeutics Inc. | 468.61M | 0.23% | 155,376 | - |
| 227 | ALLO | Allogene Therapeutics, Inc. | 459.50M | - | 4,742,434 | 4.64M |
| 228 | MPLT | MapLight Therapeutics, Inc. | 453.50M | -0.97% | 343,847 | - |
| 229 | AGMB | AgomAb Therapeutics NV | 448.65M | 4.35% | 43,231 | - |
| 230 | PROK | ProKidney Corp. | 435.34M | - | 601,286 | 818.00K |
| 231 | ALT | Altimmune, Inc. | 433.77M | -3.04% | 4,501,775 | 31.00K |
| 232 | EIKN | Eikon Therapeutics, Inc. | 433.32M | -2.20% | 240,637 | - |
| 233 | AUTL | Autolus Therapeutics plc | 431.18M | -2.41% | 1,825,370 | 117.39M |
| 234 | TECX | Tectonic Therapeutic, Inc. | 426.96M | 0.09% | 152,825 | - |
| 235 | INDP | Indaptus Therapeutics, Inc. | 421.05M | 6.76% | 528,829 | - |
| 236 | ASMB | Assembly Biosciences, Inc. | 416.58M | -3.45% | 234,769 | 74.85M |
| 237 | SPRY | ARS Pharmaceuticals, Inc. | 415.69M | -2.68% | 1,010,607 | 116.93M |
| 238 | PRTA | Prothena Corporation plc | 412.24M | -5.53% | 461,392 | 54.53M |
| 239 | TRXB | TRex Bio, Inc. | 410.29M | 5.54% | 88,605 | - |
| 240 | YDES | YD Bio Limited | 408.70M | -1.20% | 144,054 | 1.24M |
| 241 | ZURA | Zura Bio Limited | 395.77M | 3.25% | 4,188,453 | - |
| 242 | CCCC | C4 Therapeutics, Inc. | 389.99M | 0.32% | 2,189,796 | 35.04M |
| 243 | RZLT | Rezolute, Inc. | 388.12M | - | 929,975 | - |
| 244 | EDIT | Editas Medicine, Inc. | 385.49M | -2.71% | 1,139,413 | 47.01M |
| 245 | PRLD | Prelude Therapeutics Incorporated | 375.93M | 3.40% | 608,327 | 22.42M |
| 246 | SCTX | Scribe Therapeutics Inc. | 365.38M | -2.57% | 485,071 | 33.30M |
| 247 | FENC | Fennec Pharmaceuticals Inc. | 364.00M | -0.76% | 84,490 | 59.22M |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 361.17M | -3.31% | 822,902 | - |
| 249 | OBIO | Orchestra BioMed Holdings, Inc. | 348.91M | -0.26% | 485,837 | 31.98M |
| 250 | VTVT | vTv Therapeutics Inc. | 345.04M | -0.29% | 14,137 | 36.84M |
| 251 | NAUT | Nautilus Biotechnology, Inc. | 344.86M | 6.27% | 8,655,733 | 190.00K |
| 252 | RLMD | Relmada Therapeutics, Inc. | 342.41M | -4.46% | 1,720,534 | - |
| 253 | IRD | Opus Genetics, Inc. | 342.35M | 2.62% | 1,355,604 | 9.86M |
| 254 | CAPR | Capricor Therapeutics, Inc. | 341.86M | -11.04% | 3,440,920 | 11.13M |
| 255 | GALT | Galectin Therapeutics Inc. | 339.86M | -1.75% | 292,835 | - |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 329.41M | -3.08% | 166,827 | 65.26M |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 327.24M | -8.62% | 465,189 | - |
| 258 | ARTV | Artiva Biotherapeutics, Inc. | 317.30M | -1.07% | 363,942 | 251.00K |
| 259 | ARCT | Arcturus Therapeutics Holdings Inc. | 314.64M | 0.82% | 341,784 | 29.37M |
| 260 | CTNM | Contineum Therapeutics, Inc. | 314.14M | -1.30% | 1,116,667 | - |
| 261 | VOGX | Vogenx, Inc. | 302.90M | 8.75% | 84,313 | - |
| 262 | TTRX | Turn Therapeutics Inc. | 302.35M | -3.06% | 60,583 | - |
| 263 | IKT | Inhibikase Therapeutics, Inc. | 302.24M | -2.92% | 528,964 | 1.00 |
| 264 | XFOR | X4 Pharmaceuticals, Inc. | 298.43M | -0.33% | 406,817 | 15.85M |
| 265 | SRZN | Surrozen, Inc. | 297.60M | 0.72% | 118,837 | 11.51M |
| 266 | BNTC | Benitec Biopharma Inc. | 296.50M | -5.97% | 171,810 | - |
| 267 | IPSC | Century Therapeutics, Inc. | 291.53M | -1.83% | 1,645,276 | 109.16M |
| 268 | AGEN | Agenus Inc. | 288.13M | -0.31% | 789,661 | 132.69M |
| 269 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | -0.54% | 923,469 | 80.00M |
| 270 | ALEC | Alector, Inc. | 277.24M | -5.08% | 1,141,620 | 13.86M |
| 271 | OCGN | Ocugen, Inc. | 276.41M | 0.32% | 4,321,941 | 4.58M |
| 272 | CUVL | Clinuvel Pharmaceuticals Limited | 261.48M | -1.35% | - | 65.05M |
| 273 | CABA | Cabaletta Bio, Inc. | 261.10M | -4.35% | 3,046,188 | - |
| 274 | VCRE | Vicore Pharma Holding AB (publ) | 260.99M | 3.11% | 9,846 | 412.09K |
| 275 | QTTB | Q32 Bio Inc. | 258.10M | 0.58% | 322,101 | 53.74M |
| 276 | ABEO | Abeona Therapeutics Inc. | 257.90M | -1.96% | 643,535 | 25.52M |
| 277 | SABS | SAB Biotherapeutics, Inc. | 256.58M | -2.08% | 388,679 | 114.70K |
| 278 | LRMR | Larimar Therapeutics, Inc. | 252.61M | -0.82% | 1,512,840 | - |
| 279 | BCYC | Bicycle Therapeutics plc | 249.87M | -0.83% | 406,402 | 61.21M |
| 280 | FATE | Fate Therapeutics, Inc. | 248.03M | 0.49% | 1,215,097 | 6.49M |
| 281 | LXEO | Lexeo Therapeutics, Inc. | 246.13M | -0.17% | 1,080,267 | - |
| 282 | ACIU | AC Immune SA | 245.58M | -0.80% | 88,983 | 21.67M |
| 283 | PALI | Palisade Bio, Inc. | 243.98M | -2.10% | 1,433,348 | 500.00K |
| 284 | GLSI | Greenwich LifeSciences, Inc. | 243.22M | 2.03% | 82,265 | - |
| 285 | VNDA | Vanda Pharmaceuticals Inc. | 242.46M | -3.84% | 1,087,828 | 215.72M |
| 286 | IMRX | Immuneering Corporation | 241.97M | 0.27% | 478,510 | - |
| 287 | RCKT | Rocket Pharmaceuticals, Inc. | 241.50M | -5.98% | 2,023,724 | - |
| 288 | LCTX | Lineage Cell Therapeutics, Inc. | 240.64M | -2.17% | 1,220,810 | 13.08M |
| 289 | LYEL | Lyell Immunopharma, Inc. | 230.59M | -2.99% | 118,319 | 27.00K |
| 290 | MGNX | MacroGenics, Inc. | 228.68M | 2.87% | 398,263 | 175.14M |
| 291 | IFRX | InflaRx N.V. | 228.42M | 0.65% | 700,982 | -11.54K |
| 292 | ZNTL | Zentalis Pharmaceuticals, Inc. | 223.43M | -1.26% | 1,207,182 | 26.87M |
| 293 | KROS | Keros Therapeutics, Inc. | 221.67M | -1.93% | 178,028 | 15.01M |
| 294 | SLGL | Sol-Gel Technologies Ltd. | 215.17M | -0.14% | 60,525 | 1.80M |
| 295 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 214.87M | -1.47% | 942,240 | - |
| 296 | PYXS | Pyxis Oncology, Inc. | 210.24M | -4.35% | 501,330 | 11.04M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 207.07M | -2.65% | 561,517 | 80.62M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 206.46M | 4.75% | 186,414 | 4.22M |
| 299 | CGEN | Compugen Ltd. | 200.82M | -0.93% | 186,969 | 74.00M |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 194.24M | 0.31% | 105,939 | 1.48M |
| 301 | PRQR | ProQR Therapeutics N.V. | 193.34M | -0.72% | 649,194 | 21.05M |
| 302 | IVVD | Invivyd, Inc. | 188.44M | 0.42% | 5,995,719 | 58.37M |
| 303 | PEPG | PepGen Inc. | 188.39M | -5.23% | 1,174,076 | - |
| 304 | YARW | Yarrow Bioscience, Inc. | 187.67M | -0.20% | 73,495 | - |
| 305 | EVMN | Evommune, Inc. | 187.63M | -3.90% | 383,384 | 10.00M |
| 306 | WHWK | Whitehawk Therapeutics, Inc. | 187.27M | 2.98% | 279,988 | 7.15M |
| 307 | ACOG | Alpha Cognition Inc. | 186.85M | -0.35% | 88,783 | 15.26M |
| 308 | DTIL | Precision BioSciences, Inc. | 185.21M | 2.29% | 231,039 | 45.06M |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 183.83M | 0.22% | 625,500 | - |
| 310 | STRO | Sutro Biopharma, Inc. | 178.91M | -6.50% | 439,854 | 45.70M |
| 311 | SION | Sionna Therapeutics, Inc. | 174.97M | -6.75% | 1,557,305 | - |
| 312 | ORMP | Oramed Pharmaceuticals Inc. | 172.21M | -0.24% | 84,413 | 2.00M |
| 313 | TRDA | Entrada Therapeutics, Inc. | 167.66M | -6.81% | 323,804 | 4.69M |
| 314 | ADAG | Adagene Inc. | 161.82M | -3.60% | 96,527 | 9.29M |
| 315 | NGEN | NervGen Pharma Corp. | 161.28M | -2.60% | 297,513 | - |
| 316 | ALXO | ALX Oncology Holdings Inc. | 159.02M | -7.26% | 934,509 | - |
| 317 | NBP | NovaBridge Biosciences | 158.92M | -3.86% | 586,667 | - |
| 318 | CHRS | Coherus Oncology, Inc. | 157.59M | 2.00% | 1,277,239 | 50.94M |
| 319 | MDWD | MediWound Ltd. | 156.21M | - | 155,321 | 11.86M |
| 320 | CNTN | Canton Strategic Holdings, Inc. | 153.79M | 11.56% | 847,521 | 1.50M |
| 321 | UPB | Upstream Bio, Inc. | 153.36M | -0.71% | 1,410,486 | 3.16M |
| 322 | VRXA | Veraxa Biotech AG | 149.89M | 4.95% | 197,992 | 29.54K |
| 323 | TARA | Protara Therapeutics, Inc. | 147.74M | -2.34% | 971,146 | - |
| 324 | ABOS | Acumen Pharmaceuticals, Inc. | 146.80M | 0.74% | 397,630 | - |
| 325 | CMPX | Compass Therapeutics, Inc. | 146.68M | -2.26% | 1,543,722 | 850.00K |
| 326 | MSLE | Satellos Bioscience Inc. | 143.59M | -4.29% | 28,297 | - |
| 327 | IPHA | Innate Pharma S.A. | 141.74M | -0.51% | - | 11.21M |
| 328 | CDXS | Codexis, Inc. | 141.26M | 4.88% | 1,058,060 | 77.68M |
| 329 | MOLN | Molecular Partners AG | 141.15M | 0.54% | 3,145 | 856.30K |
| 330 | MENS | Jyong Biotech Ltd. | 140.30M | 1.61% | 25,565 | - |
| 331 | CUE | Cue Biopharma, Inc. | 137.66M | 11.21% | 112,223 | 37.66M |
| 332 | RNA | Atrium Therapeutics, Inc. | 136.85M | 0.25% | 193,206 | 35.84M |
| 333 | KRRO | Korro Bio, Inc. | 136.80M | -1.59% | 115,946 | 2.38M |
| 334 | OTLK | Outlook Therapeutics, Inc. | 136.65M | 7.94% | 2,996,944 | -1.16M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 135.85M | 1.12% | 177,366 | - |
| 336 | HURA | TuHURA Biosciences, Inc. | 132.87M | 18.47% | 1,079,336 | - |
| 337 | TLSA | Tiziana Life Sciences Ltd | 129.31M | - | 421,474 | - |
| 338 | AVXL | Anavex Life Sciences Corp. | 126.07M | - | 1,055,177 | - |
| 339 | NKTX | Nkarta, Inc. | 125.34M | 0.57% | 1,088,375 | - |
| 340 | RTSN | Retension Pharmaceuticals, Inc. | 124.97M | -7.29% | 110,572 | - |
| 341 | VYGR | Voyager Therapeutics, Inc. | 124.47M | -7.76% | 935,813 | 34.46M |
| 342 | SPRB | Spruce Biosciences, Inc. | 122.81M | 3.64% | 61,504 | 697.00K |
| 343 | FHTX | Foghorn Therapeutics Inc. | 120.85M | 1.24% | 819,311 | 36.74M |
| 344 | BDTX | Black Diamond Therapeutics, Inc. | 119.50M | 0.48% | 2,355,482 | 70.00M |
| 345 | HUMA | Humacyte, Inc. | 114.23M | 1.28% | 4,172,426 | 2.12M |
| 346 | NERV | Minerva Neurosciences, Inc. | 114.12M | -5.53% | 102,608 | - |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 113.78M | 0.38% | 526,481 | 3.39M |
| 348 | ARMP | Armata Pharmaceuticals, Inc. | 113.78M | -4.38% | 93,557 | 5.54M |
| 349 | SEER | Seer, Inc. | 112.41M | 2.53% | 121,992 | 14.22M |
| 350 | KZIA | Kazia Therapeutics Limited | 112.10M | 3.81% | 164,501 | 1.27M |
| 351 | ENGN | enGene Therapeutics Inc. | 109.24M | -2.40% | 1,108,857 | - |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 107.80M | 1.84% | 1,439,342 | - |
| 353 | CBUS | Cibus, Inc. | 107.76M | 1.44% | 44,995 | 4.35M |
| 354 | VANI | Vivani Medical, Inc. | 104.64M | 3.57% | 161,150 | - |
| 355 | PYPD | PolyPid Ltd. | 102.98M | -1.55% | 137,081 | - |
| 356 | PMVP | PMV Pharmaceuticals, Inc. | 102.70M | -2.16% | 236,573 | - |
| 357 | IMUX | Immunic, Inc. | 102.06M | 0.94% | 329,656 | - |
| 358 | TVGN | Tevogen Inc. | 101.34M | -5.57% | 737 | - |
| 359 | LENZ | LENZ Therapeutics, Inc. | 101.17M | 0.94% | 943,222 | 21.48M |
| 360 | NRXS | NeurAxis, Inc. | 99.46M | 1.28% | 66,942 | 5.32M |
| 361 | MIST | Milestone Pharmaceuticals Inc. | 97.98M | -3.23% | 673,189 | 2.34M |
| 362 | COYA | Coya Therapeutics, Inc. | 97.12M | -1.66% | 95,099 | 8.02M |
| 363 | PLYX | Polaryx Therapeutics, Inc. | 96.70M | 1.57% | 13,296 | - |
| 364 | AARD | Aardvark Therapeutics, Inc. | 96.51M | 13.08% | 218,435 | - |
| 365 | ICCC | ImmuCell Corporation | 95.54M | 0.67% | 7,127 | 30.68M |
| 366 | ANIX | Anixa Biosciences, Inc. | 94.21M | 1.12% | 115,718 | - |
| 367 | CNXU | Conexeu Sciences Inc. | 93.93M | 11.37% | 417,784 | - |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 93.85M | 2.07% | 26,543 | 6.19M |
| 369 | TENX | Tenax Therapeutics, Inc. | 93.37M | - | 2,353,313 | - |
| 370 | OKUR | OnKure Therapeutics, Inc. | 93.14M | -2.54% | 232,756 | - |
| 371 | TNXP | Tonix Pharmaceuticals Holding Corp. | 93.13M | -6.06% | 874,997 | 29.10M |
| 372 | GNLX | Genelux Corporation | 92.76M | -17.20% | 850,543 | 8.00K |
| 373 | EQ | Equillium, Inc. | 90.04M | 2.90% | 442,539 | 4.39M |
| 374 | PDSB | PDS Biotechnology Corporation | 89.87M | 29.10% | 15,239,955 | - |
| 375 | TNYA | Tenaya Therapeutics, Inc. | 87.49M | -4.83% | 2,185,633 | 1.34M |
| 376 | RLYB | Rallybio Corporation | 86.14M | -0.98% | 13,640 | 646.00K |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 84.33M | -7.32% | 688,219 | 4.88M |
| 378 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 82.88M | -3.05% | 625,859 | - |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 82.23M | -21.26% | 11,649,288 | 65.34K |
| 380 | PMN | ProMIS Neurosciences, Inc. | 81.88M | 12.86% | 7,482 | - |
| 381 | CLLS | Cellectis S.A. | 81.17M | -2.17% | 282,094 | 63.82M |
| 382 | OKYO | OKYO Pharma Limited | 80.82M | 12.41% | 241,045 | - |
| 383 | ACRV | Acrivon Therapeutics, Inc. | 78.21M | 1.67% | 159,022 | - |
| 384 | NMRA | Neumora Therapeutics, Inc. | 78.16M | -10.54% | 1,577,541 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 75.09M | 0.99% | 38,092 | - |
| 386 | NTRB | Nutriband Inc. | 74.64M | 4.96% | 22,076 | 1.62M |
| 387 | CRDF | Cardiff Oncology, Inc. | 73.05M | 0.81% | 436,773 | 508.00K |
| 388 | NTHI | NeOnc Technologies Holdings, Inc. | 72.08M | 4.69% | 106,148 | 39.99K |
| 389 | PTHS | Pelthos Therapeutics Inc. | 71.59M | -8.78% | 99,149 | 43.30M |
| 390 | CGTX | Cognition Therapeutics, Inc. | 71.00M | 1.74% | 297,039 | - |
| 391 | MNOV | MediciNova, Inc. | 69.40M | 3.68% | 32,599 | 920.48K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 69.34M | 1.79% | 107,870 | - |
| 393 | SPRO | Spero Therapeutics, Inc. | 68.13M | -4.10% | 265,711 | 47.00M |
| 394 | CING | Cingulate Inc. | 67.76M | 2.87% | 132,399 | - |
| 395 | CSBR | Champions Oncology, Inc. | 67.51M | 0.83% | - | 60.66M |
| 396 | ONCY | Oncolytics Biotech Inc. | 65.21M | 2.57% | 771,634 | - |
| 397 | FBIO | Fortress Biotech, Inc. | 64.70M | - | 178,188 | 68.47M |
| 398 | HRTX | Heron Therapeutics, Inc. | 64.32M | -4.43% | 3,165,409 | 151.18M |
| 399 | VRCA | Verrica Pharmaceuticals Inc. | 62.36M | 4.61% | 60,439 | 30.32M |
| 400 | XBIT | XBiotech Inc. | 60.67M | -1.73% | 58,251 | - |
| 401 | GOSS | Gossamer Bio, Inc. | 59.88M | 2.19% | 218,868 | 53.29M |
| 402 | HYFT | MindWalk Holdings Corp. | 59.83M | -1.55% | 113,372 | 11.57M |
| 403 | OSTX | OS Therapies Incorporated | 58.68M | 0.79% | 338,045 | - |
| 404 | CRBU | Caribou Biosciences, Inc. | 58.36M | 4.89% | 2,264,019 | 10.04M |
| 405 | RNXT | RenovoRx, Inc. | 55.51M | 2.50% | 403,709 | 1.98M |
| 406 | BOLD | Boundless Bio, Inc. | 55.50M | 0.41% | 64,262 | - |
| 407 | XLO | Xilio Therapeutics, Inc. | 55.47M | -1.29% | 36,265 | 64.09M |
| 408 | ALPS | Alps Group Inc | 54.91M | - | - | 3.74M |
| 409 | PLRX | Pliant Therapeutics, Inc. | 54.85M | -2.92% | 340,621 | - |
| 410 | INKT | MiNK Therapeutics, Inc. | 54.19M | 7.71% | 18,490 | - |
| 411 | IBIO | iBio, Inc. | 54.02M | 2.31% | 517,429 | 100.00K |
| 412 | RNTX | Rein Therapeutics Inc. | 53.90M | 4.99% | 266,088 | - |
| 413 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.68M | 0.61% | 16,274 | - |
| 414 | CLNN | Clene Inc. | 53.44M | 0.80% | 84,555 | 197.00K |
| 415 | LONA | LeonaBio, Inc. | 53.42M | 7.59% | 11,765 | - |
| 416 | GANX | Gain Therapeutics, Inc. | 51.94M | - | 609,403 | - |
| 417 | CNTB | Connect Biopharma Holdings Limited | 50.26M | -8.81% | 1,582,139 | 2.95M |
| 418 | HOWL | Werewolf Therapeutics, Inc. | 50.06M | -1.90% | 199,336 | 21.00M |
| 419 | BMEA | Biomea Fusion, Inc. | 50.02M | -6.19% | 3,040,670 | - |
| 420 | ACET | Adicet Bio, Inc. | 48.33M | -0.66% | 181,991 | - |
| 421 | HYPD | Hyperion DeFi, Inc. | 48.17M | 4.20% | 145,102 | 1.40M |
| 422 | KLRS | Kalaris Therapeutics, Inc. | 48.09M | -2.42% | 84,353 | - |
| 423 | APLM | Apollomics, Inc. | 47.42M | -2.07% | 3,248 | 8.84M |
| 424 | MREO | Mereo BioPharma Group plc | 46.50M | -1.32% | 330,185 | 500.00K |
| 425 | IMA | ImageneBio, Inc. | 46.37M | -1.09% | 7,087 | 800.00K |
| 426 | SER | Serina Therapeutics, Inc. | 44.96M | 6.63% | 39,787 | 130.00K |
| 427 | INMB | INmune Bio Inc. | 44.68M | 0.63% | 229,866 | 50.00K |
| 428 | ELTX | Elicio Therapeutics, Inc. | 43.89M | 6.37% | 269,879 | - |
| 429 | ATNM | Actinium Pharmaceuticals, Inc. | 43.39M | -1.43% | 358,232 | 35.09M |
| 430 | ANVS | Annovis Bio, Inc. | 42.32M | 1.52% | 546,328 | - |
| 431 | GRCE | Grace Therapeutics, Inc. | 41.44M | -0.51% | 77,003 | - |
| 432 | ATHE | Alterity Therapeutics Limited | 41.05M | -1.05% | 56,523 | 2.50M |
| 433 | ALDX | Aldeyra Therapeutics, Inc. | 40.44M | -8.72% | 606,565 | - |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 39.77M | 1.74% | 40,036 | - |
| 435 | VERU | Veru Inc. | 39.22M | -3.36% | 99,717 | 16.89M |
| 436 | TIL | Instil Bio, Inc. | 39.13M | -2.86% | 40,868 | - |
| 437 | NNVC | NanoViricides, Inc. | 38.54M | 2.03% | 206,643 | - |
| 438 | EDSA | Edesa Biotech, Inc. | 38.51M | 1.06% | 39,166 | - |
| 439 | LITS | Lite Strategy, Inc. | 37.71M | 4.20% | 164,222 | - |
| 440 | EYPT | EyePoint, Inc. | 37.07M | 6.12% | 31,692,669 | 2.79M |
| 441 | EXOZ | eXoZymes, Inc. | 36.38M | -4.85% | 19,967 | -700.00 |
| 442 | CRVO | CervoMed Inc. | 35.38M | 2.18% | 78,557 | 331.30K |
| 443 | IRLA | IRulya Therapeutics Inc. | 35.27M | -13.88% | 216,319 | - |
| 444 | GRDX | GridAI Technologies Corp. | 34.70M | 5.83% | 76,831 | - |
| 445 | IBO | Impact BioMedical Inc. | 34.35M | 23.01% | - | 35.00K |
| 446 | CELU | Celularity Inc. | 33.10M | -19.05% | 204,539 | 18.67M |
| 447 | FLNA | Filana Therapeutics, Inc. | 31.85M | -4.24% | 306,437 | - |
| 448 | BCTX | BriaCell Therapeutics Corp. | 31.42M | 4.05% | 24,950 | - |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 31.31M | -0.30% | 85,776 | 13.56M |
| 450 | BSEM | BioStem Technologies, Inc. | 31.22M | 2.44% | 197,223 | 34.59M |
| 451 | ALGS | Aligos Therapeutics, Inc. | 30.97M | -1.39% | 13,104 | 31.52M |
| 452 | EVAX | Evaxion A/S | 30.94M | -8.40% | 326,107 | 7.49M |
| 453 | CVM | CEL-SCI Corporation | 28.49M | 4.52% | 149,412 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 28.11M | -1.19% | 16,753 | - |
| 455 | ABVC | ABVC BioPharma, Inc. | 25.92M | 7.53% | 49,336 | 797.92K |
| 456 | ATOS | Atossa Therapeutics, Inc. | 25.25M | -0.39% | 189,488 | - |
| 457 | IGC | IGC Pharma, Inc. | 25.07M | -1.02% | 368,323 | 1.11M |
| 458 | IMMP | Immutep Limited | 24.85M | 0.61% | 8,209 | 13.79M |
| 459 | NXTC | NextCure, Inc. | 24.79M | -0.46% | 71,520 | - |
| 460 | ESLA | Estrella Immunopharma, Inc. | 23.92M | 37.50% | 7,019,431 | - |
| 461 | MCRB | Seres Therapeutics, Inc. | 23.10M | -0.43% | 41,764 | 1.88M |
| 462 | PLRZ | Polyrizon Ltd. | 22.34M | 0.55% | 6,929 | - |
| 463 | CNTX | Context Therapeutics Inc. | 21.26M | -5.09% | 1,167,039 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 21.10M | -1.33% | 11,793 | 4.62M |
| 465 | BYSI | BeyondSpring Inc. | 20.39M | -5.13% | 37,274 | 1.88M |
| 466 | AKTX | Akari Therapeutics, Plc | 20.02M | -5.71% | 30,596 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 19.41M | -1.23% | 90,606 | - |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.17M | -1.24% | 7,752 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 18.84M | -2.59% | 149,938 | 3.55M |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 18.83M | 2.65% | 8,797 | 1.17M |
| 471 | COCP | Cocrystal Pharma, Inc. | 18.18M | 0.07% | 7,548 | 330.00K |
| 472 | PBM | Psyence Biomedical Ltd. | 17.24M | 6.60% | 39,286 | - |
| 473 | NCEL | NewcelX Ltd. | 17.04M | 13.03% | 12,071 | - |
| 474 | ATYR | aTyr Pharma, Inc. | 16.90M | -0.58% | 1,234,525 | 190.00K |
| 475 | JSPR | Jasper Therapeutics, Inc. | 16.78M | 0.88% | 358,451 | - |
| 476 | ICU | SeaStar Medical Holding Corporation | 16.68M | 3.93% | 80,681 | 1.71M |
| 477 | KTTA | Pasithea Therapeutics Corp. | 16.30M | 18.98% | 782,026 | - |
| 478 | GUTS | Fractyl Health, Inc. | 15.25M | -13.53% | 1,011,746 | 3.00K |
| 479 | TCRX | TScan Therapeutics, Inc. | 15.18M | - | 689,444 | 7.11M |
| 480 | KPRX | Kiora Pharmaceuticals, Inc. | 14.89M | 0.43% | 30,132 | 20.00K |
| 481 | BCDA | BioCardia, Inc. | 14.87M | -5.54% | 133,370 | 3.00K |
| 482 | DYAI | Dyadic International, Inc. | 14.58M | 3.87% | - | 3.80M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 14.00M | 0.43% | 88,745 | 345.00K |
| 484 | RADX | Radiopharm Theranostics Limited | 13.71M | -1.13% | 14,360 | 8.90M |
| 485 | TVRD | Tvardi Therapeutics, Inc. | 13.61M | 2.82% | 137,101 | - |
| 486 | DARE | Daré Bioscience, Inc. | 13.53M | -0.15% | 24,604 | 1.37M |
| 487 | ACTU | Actuate Therapeutics, Inc. | 13.50M | -8.75% | 220,566 | - |
| 488 | LPCN | Lipocine Inc. | 13.19M | -1.23% | 160,672 | 1.57M |
| 489 | CNSY | Cerenome, Inc. | 13.13M | 2.98% | 53,818 | 4.20M |
| 490 | PLUR | Pluri Inc. | 12.96M | 16.67% | 50,163 | 1.02M |
| 491 | HIND | Vyome Holdings, Inc. | 12.91M | - | 2,189 | 129.73K |
| 492 | CLRB | Cellectar Biosciences, Inc. | 12.10M | 4.07% | 134,948 | - |
| 493 | AEON | AEON Biopharma, Inc. | 11.98M | 3.76% | 145,655 | - |
| 494 | BLRX | BioLineRx Ltd. | 11.62M | -4.74% | 1,821 | 1.39M |
| 495 | PASG | Passage Bio, Inc. | 11.55M | -0.28% | 2,905 | - |
| 496 | GDTC | CytoMed Therapeutics Limited | 10.97M | 5.45% | 4,986 | 609.73K |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 10.86M | -5.27% | 383,635 | 7.11M |
| 498 | ADIL | Adial Pharmaceuticals, Inc. | 10.79M | 7.59% | 21,497 | - |
| 499 | INAB | IN8bio, Inc. | 10.75M | -4.39% | 32,212 | - |
| 500 | PPBT | Purple Biotech Ltd | 10.49M | 5.99% | 9,986 | - |